19
Views
15
CrossRef citations to date
0
Altmetric
Research Article

G2 chromosomal radiosensitivity in fibroblasts of ataxia-telangiectasia heterozygotes and a Li-Fraumeni Syndrome patient with radioresistant cells

Pages 435-438 | Published online: 03 Jul 2009

References

  • BIRCH, J. M., HARTLEY, L., TRICKER, K. J., PROSSER, J., CUNDIE, A., KELSEY, A. M., HARRIS, M., MORRIS JONES, P. H., BINCHY, A., CROWTHER, D., CRAFT, A. W., EDEN, 0. B., EVANS, G. R., THOMPSON, E., MANN, J. R., MARTIN, J., MITCHELL, E. L. D. and SANTIBANEZ-KOREF, M. F., 1994, Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li—Fraumeni families. Cancer Research, 54, 1298–1304.
  • BIRRELL, G. W. and RAMSAY, J. R., 1995, Induction of p53 protein by gamma radiation in lymphocyte lines from breast cancer and ataxia-telangiectasia patients. British Journal of Cancer, 72, 1096–1101.
  • EASTON, D. F., 1994, Cancer risks in A-T heterozygotes. International Journal of Radiation Biology, 66, 5177–5182.
  • HEIM, S. and MITELMAN, F., 1996, Cancer Cytogenetics (New York: Wiley-Liss).
  • HITTELMAN, W. N. and PANDITA, T. 1(.7 1994, Possible role of chromatin alteration in the radiosensitivity of ataxia-telangiectasia. International Journal of Radiation Biology, 66, 109–113.
  • JONES, L. A., SCOTT, D., COWAN, R. and ROBERT SS. A" 1995, Abnormal radiosensitivity of lymphocytes from breast cancer patients with excessive normal tissue damage after radiotherapy: chromosome aberrations after low dose-rate irradiation. International Journal of Radiation Biology, 67, 519–528.
  • KASTAN, M. B., ONYEKWERE, 0., SIDRANSKY, D., VOGELSTEIN, B. and CRAIG, R. W., 1991, Participation of the p53 protein in the cellular response to the DNA damage. Cancer Research, 51, 6304–6311.
  • LANE, D. P., 1992, p53, guardian of the genome. Nature, 358, 15–16.
  • MALKIN, D., LI, F. P., STRONG, L. C., FRAUMENI, J. F., NELSON, C. E., KIM, D. H., KAssEL, J., GRYKA, M. A., BiscHoEE, F. Z., TAINsKy, M. A. and FRIEND, S. H., 1990, Germline p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science, 250, 1233–1238.
  • MOZDARANI, H. and BRYANT, P. E., 1989, Kinetics of chromatid aberrations in G2 ataxia-telangiectasia cells exposed to X-rays and AraA. International Journal of Radiation Biology, 55, 71–84.
  • NATARAJAN, A. T., MELIERS, M., VAN ZEELAND, A. A. and SimoNs, J. W. I. M., 1982, Attempts to detect ataxia telangiectasia (A-T) heterozygotes by cytogenetical tech-niques. Cytogenetics and Cell Genetics, 33, 145–151.
  • PARSHAD, R., PRICE, F. M., PIROLLO, K. M., CHANG, E. H. and SANFORD, K. K., 1993, Cytogenetic response to G2-phase X irradiation in relation to DNA repair and radio-sensitivity in a cancer-prone family with Li—Fraumeni syndrome. Radiation Research, 136, 236–240.
  • PARSHAD, R., SANFORD, K. K., JONES, G. M. and TARONE, R. E., 1985, G2 chromosomal radiosensitivity of ataxia-telangiectasia heterozygotes. cancer Genetics and Cytogenetics, 14, 163–168.
  • SANFORD, K. K. and PARSHAD, R., 1990, Detection of cancer prone individuals using cytogenetic response to X-rays. In Chromosomal Aberrations: Basic and Applied Aspects, edited by G. Obe and A. T. Natarajan (Berlin: Springer), pp. 113–120.
  • SANFORD, K. K., PARSHAD, R., GANTT, R., TARONE, R. E., JONES, G. M. and PRICE, F. M., 1989, Factors affecting and significance of G2 chromatin radiosensitivity in pre-disposition to cancer. International Journal of Radiation Biology, 55, 963–981.
  • SANFORD, K. K., PARSHAD, R., PRICE, F. M., JONES, G. M., TARONE, R. E., HALE, P. and WALDMANN, T. A" 1990, Enhanced chromatid damage in blood lymphocytes after G2 phase X-irradiation, a marker of the ataxia-telangiectasia gene. Journal of the National Cancer Institute, 82, 1050–1054.
  • SCOTT, D., Hu, Q. and ROBERTS, S. A., 1996b, Dose rate sparing for micronucleus induction in lymphocytes of controls and ataxia-telangiectasia heterozygotes exposed to mCo y-irradiation in vitro. International J ournal of Radiation Biology, 70, 521–527.
  • SCOTT, D., JONES, S. A., ELYAN, S. A. G., SPREADBOROUGH, A., COWAN, R. and RIBIERO, G., 1993, Identification of A-T heterozygotes. In Ataxia- telangiectasia, edited by R. A. Gatti and R. B. Painter (Berlin: Springer), pp. 101–116.
  • SCOTT, D., SPREADBOROUGH, A., JONES, L. A., ROBERTS, S. A. and MOORE, C. J., 1996a, Chromosomal radiosensitivity in G2-phase lymphocytes as an indicator of cancer predis-position. Radiation Research, 145, 3–16.
  • SCOTT, D., SPREADBOROUGH, A., LEVINE, E. and ROBERTS, S. A., 1994, Genetic predisposition in breast cancer. Lancet, 344, 1444.
  • SHILOH, Y., PARSHAD, C., FRYDMAN, M., SANFORD, K. K., PORTNOI, S., ZIV, Y. and JONES, G. M.7 1989, G2 chromosomal radiosensitivity in families with ataxia-telangiectasia. Human Genetics, 84, 15–18.
  • SHILOH, Y PARSHAD., SANFORD, K. K. and JONES, G. M., 1986, Carrier detection in ataxia-telangiectasia. Lancet, i, 689–690.
  • SPROSTON, A. R. M., BOYLE, J. M., HEIGHWAY, J., BIRCH, J. M. and SCOTT, D., 1996, Fibroblasts from Li—Fraumeni patients are resistant to low dose rate irradiation. International Journal of Radiation Biology, 70, 145–150.
  • TAYLOR, A. M. R., 1983, The effect of radiation on the chromosomes of patients with an unusual cancer suscepti-bility. In Radiation Induced Chromosome Damage in Man, edited by T. Ishikara and M. Sasaki (New York: A. R. Liss), pp. 166–199.
  • TAYLOR, A. M. R., HARNDEN, D. G., ARLETT, C. F., HARCOURT, S. A., LEHMANN, A. R., STEVENS, S. and BRIDGES, B. A" 1975, Ataxia-telangiectasia: a human mutation with abnormal radiation sensitivity. Nature, 258, 427–429.
  • WANG, L. CUI, Y., LORD, B. I., ROBERTS, S. A., POTTEN, C. S., HENDRY, J. H. and SCOTT, D, 1996, Gamma-ray-induced cell killing and chromosome abnormalities in bone marrow of p53 deficient mice. Radiation Research, 146, 159–266.
  • WEEKS, D. E., PATERSON, M. C., LANGE, K., ANDRIAS, B., DAVIS, R. C., VODER, F. and GATTI, R. A., 1991, Assessment of chronic y radiosensitivity an in vitro assay for heterozygote identification of ataxia-telangiectasia. Radiation Research, 128, 90–99.
  • WILLIAMS, K. J., BOYLE, J. M., BIRCH, J. M., NORTON, J. D. and SCOTT, D., 1996, Cell cycle arrest defect in Li—Fraumeni Syndrome: a mechanism of cancer predisposition? oncogene, 14, 277–282.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.